Učitavanje...

Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea

INTRODUCTION: Globally, pneumococcal disease represents a significant burden. South Korea implemented the 7-valent pneumococcal conjugate vaccine (PCV7) in 2003, replaced with the 10-valent (PCV10) and 13-valent (PCV13) vaccine in 2010. In 2014, both vaccines were introduced in the national immuniza...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Hum Vaccin Immunother
Glavni autori: Kim, Hye-Young, Park, Seong-Beom, Kang, Eun-Sil, Lee, Sang-Min, Kim, Hyun-Jin, Wasserman, Matt
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7993233/
https://ncbi.nlm.nih.gov/pubmed/32783576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2020.1796426
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!